Find a Trial
Trial Results
6 protocol(s) meet the specified criteria
CTO-208887OPEN TO ACCRUAL
A Phase I/II Randomized, Open-label Platform Study Utilizing a Master Protocol to Study Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination with Anti-Cancer Treatments in Participants with Relapsed/Refractory Multiple Myeloma (RRMM) - DREAMM5
CTO-64007957MMY1004OPEN TO ACCRUAL
A Multi-arm Phase 1b Study of Teclistamab With Other Anticancer Therapies in
Participants with Multiple Myeloma
CTO-64407564MMY1004OPEN TO ACCRUAL
A Multi-arm Phase 1b Study of Talquetamab With Other Anticancer Therapies in
Participants with Multiple Myeloma
CTO-R5458-ONC-1826OPEN TO ACCRUAL
A Phase 1/2 FIH Study of REGN5458 (anti-BCMA x anti-CD3 Bispecific Antibody) in Patients with Relapsed or Refractory Multiple Myeloma
IUCRO-0381OPEN TO ACCRUAL
Role of Microenvironmental-Derived AXII in Myeloma Bone Disease: An Exploratory Model
IUCRO-0498OPEN TO ACCRUAL
Role of Osteocytes in Myeloma Bone Disease
